Left Atrial Coupling Index Predicts Heart Failure in Patients with End Stage Renal Disease

Fulya Avcı Demir1,2, Gülsüm Bingöl3,4, Mustafa Uçar5

  • 1Department of Cardiology, Medical Park Hospital, 07160 Antalya, Turkey.

PubMed

Insights

The left atrial coupling index (LACI) effectively predicts heart failure with preserved ejection fraction (HFpEF) in end-stage renal disease (ESRD) patients. This simple echocardiographic measure offers valuable insights for clinical practice.

Area of Science:

  • Cardiology
  • Nephrology
  • Echocardiography

Background:

  • End-stage renal disease (ESRD) significantly increases cardiovascular risk.
  • Heart failure with preserved ejection fraction (HFpEF) is a common complication in ESRD patients.
  • Predictive markers for HFpEF in ESRD are crucial for early intervention.

Purpose of the Study:

  • To evaluate the predictive capability of the left atrial coupling index (LACI) for HFpEF in ESRD patients.
  • To compare LACI's predictive power against other echocardiographic parameters.
  • To assess the clinical utility of LACI in routine practice.

Main Methods:

  • Retrospective study of 100 non-dialysis ESRD patients (18-65 years).
  • Patients categorized into HFpEF and non-HFpEF groups.
  • LACI calculated as Left Atrial Volume Index (LAVI) / a' wave (Tissue Doppler Imaging).
  • Statistical analysis included univariate and multivariate regression.

Main Results:

  • Patients with HFpEF showed significantly higher LACI values.
  • LACI demonstrated superior predictive capacity for HFpEF compared to LAVI and other echocardiographic measures.
  • Regression analyses confirmed LACI as a strong independent predictor.

Conclusions:

  • Elevated LACI levels are strongly associated with the presence of HFpEF in ESRD.
  • LACI is a readily obtainable and valuable echocardiographic marker for HFpEF assessment in ESRD.
  • The findings support LACI's integration into routine echocardiographic evaluations for this population.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69